Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the SkinE. Maubec, Marie‐Françoise Avril|Journal of Clinical Oncology|2011Cited by 463
Mature Cytotoxic CD56bright/CD16 <i>+</i> Natural Killer Cells Can Infiltrate Lymph Nodes Adjacent to Metastatic MelanomaMeriem Messaoudene, Anne Caignard, Giulia Fregni et al.|Cancer Research|2013Cited by 93
Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal MelanomaC. Mignard, P. Joly, Aurélie Deschamps Huvier et al.|Journal of Oncology|2018Cited by 82
Phenotypic and Functional Characteristics of Blood Natural Killer Cells from Melanoma Patients at Different Clinical StagesGiulia Fregni, Anne Caignard, Meriem Messaoudene et al.|PLoS ONE|2013Cited by 65
Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohortM. Kandel, Isabelle Borget, Caroline Dutriaux et al.|European Journal of Cancer|2018Cited by 38